Lipodystrophy and severe metabolic dysfunction in mice with adipose tissue-specific insulin receptor ablation

Molecular Metabolism

Volumn 5, Issue 7, 2016, Pages 480-490

  Qiang, Guifen ^a   Whang Kong, Hyerim ^a   Xu, Shanshan ^a   Pham, Hoai An ^b   Parlee, Sebastian D ^b   Burr, Aaron A ^b   Gil, Victoria ^a   Pang, Jingbo ^a   Hughes, Amy ^a   Gu, Xuejiang ^a,c   Fantuzzi, Giamila ^a   MacDougald, Ormond A ^b   Liew, Chong Wee ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c THE FIRST AFFILIATED HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Brown adipose tissue; Insulin signaling; Lipodystrophy; Marrow adipose tissue; White adipose tissue

Indexed keywords

ADIPOCYTOKINE; INSULIN RECEPTOR;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BROWN ADIPOCYTE; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE SEVERITY; FEMALE; HYPERGLYCEMIA; INSULIN RESISTANCE; LIPID STORAGE; LIPODYSTROPHY; MALE; METABOLIC DISORDER; METABOLIC REGULATION; METABOLISM; MOUSE; MOUSE STRAIN; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TISSUE SPECIFICITY; WHITE ADIPOCYTE;

EID: 84969544817     PISSN: 22128778     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmet.2016.05.005     Document Type: Article

References (63)

1. Cinti S. The adipose organ: morphological perspectives of adipose tissues. Proceedings of the Nutrition Society 2001, 60(3):319-328.
2. Ailhaud G., Grimaldi P., Negrel R. Cellular and molecular aspects of adipose tissue development. Annual Review of Nutrition 1992, 12:207-233.
3. Klaus S. Adipose tissue as a regulator of energy balance. Current Drug Targets 2004, 5(3):241-250.
4. Lee M.J., Fried S.K. Integration of hormonal and nutrient signals that regulate leptin synthesis and secretion. American Journal of Physiology, Endocrinology & Metabolism 2009, 296(6):E1230-E1238.
5. Liu L., Karkanias G.B., Morales J.C., Hawkins M., Barzilai N., Wang J., et al. Intracerebroventricular leptin regulates hepatic but not peripheral glucose fluxes. Journal of Biological Chemistry 1998, 273(47):31160-31167.
6. Yamauchi T., Kamon J., Waki H., Terauchi Y., Kubota N., Hara K., et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nature Medicine 2001, 7(8):941-946.
7. Guilherme A., Virbasius J.V., Puri V., Czech M.P. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nature Reviews Molecular Cell Biology 2008, 9(5):367-377.
8. Mathieu P., Lemieux I., Despres J.P. Obesity, inflammation, and cardiovascular risk. Clinical Pharmacology & Therapeutics 2010, 87(4):407-416.
9. Ouchi N., Parker J.L., Lugus J.J., Walsh K. Adipokines in inflammation and metabolic disease. Nature Reviews Immunology 2011, 11(2):85-97.
10. Huang-Doran I., Sleigh A., Rochford J.J., O'Rahilly S., Savage D.B. Lipodystrophy: metabolic insights from a rare disorder. Journal of Endocrinology 2010, 207(3):245-255.
11. Berardinelli W. An undiagnosed endocrinometabolic syndrome: report of 2 cases. Journal of Clinical Endocrinology & Metabolism 1954, 14(2):193-204.
12. Seip M. Lipodystrophy and gigantism with associated endocrine manifestations. A new diencephalic syndrome?. Acta Paediatrica 1959, 48:555-574.
13. Accili D., Drago J., Lee E.J., Johnson M.D., Cool M.H., Salvatore P., et al. Early neonatal death in mice homozygous for a null allele of the insulin receptor gene. Nature Genetics 1996, 12(1):106-109.
14. Michael M.D., Kulkarni R.N., Postic C., Previs S.F., Shulman G.I., Magnuson M.A., et al. Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Molecular Cell 2000, 6(1):87-97.
15. Kulkarni R.N., Bruning J.C., Winnay J.N., Postic C., Magnuson M.A., Kahn C.R. Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell 1999, 96(3):329-339.
16. Bruning J.C., Gautam D., Burks D.J., Gillette J., Schubert M., Orban P.C., et al. Role of brain insulin receptor in control of body weight and reproduction. Science 2000, 289(5487):2122-2125.
17. Kim J.K., Michael M.D., Previs S.F., Peroni O.D., Mauvais-Jarvis F., Neschen S., et al. Redistribution of substrates to adipose tissue promotes obesity in mice with selective insulin resistance in muscle. Journal of Clinical Investigation 2000, 105(12):1791-1797.
18. Lee K.Y., Russell S.J., Ussar S., Boucher J., Vernochet C., Mori M.A., et al. Lessons on conditional gene targeting in mouse adipose tissue. Diabetes 2013, 62(3):864-874.
19. Balen A.H. Ovulation induction in the management of anovulatory polycystic ovary syndrome. Molecular and Cellular Endocrinology 2013, 373(1-2):77-82.
20. Acosta T.J., Yoshizawa N., Ohtani M., Miyamoto A. Local changes in blood flow within the early and midcycle corpus luteum after prostaglandin F(2 alpha) injection in the cow. Biology of Reproduction 2002, 66(3):651-658.
21. Makowski L., Boord J.B., Maeda K., Babaev V.R., Uysal K.T., Morgan M.A., et al. Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis. Nature Medicine 2001, 7(6):699-705.
22. Andrieu T., Feral C., Joubert M., Benhaim A., Mittre H. The absence of a functional nuclear receptor element A (NREA) in the promoter II of the aromatase P450 gene in rabbit granulosa cells. The Journal of Steroid Biochemistry and Molecular Biology 2006, 101(2-3):127-135.
23. Bluher M., Kahn B.B., Kahn C.R. Extended longevity in mice lacking the insulin receptor in adipose tissue. Science 2003, 299(5606):572-574.
24. Bluher M., Michael M.D., Peroni O.D., Ueki K., Carter N., Kahn B.B., et al. Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance. Developmental Cell 2002, 3(1):25-38.
25. Eguchi J., Wang X., Yu S., Kershaw E.E., Chiu P.C., Dushay J., et al. Transcriptional control of adipose lipid handling by IRF4. Cell Metabolism 2011, 13(3):249-259.
26. Jeffery E., Berry R., Church C.D., Yu S., Shook B.A., Horsley V., et al. Characterization of Cre recombinase models for the study of adipose tissue. Adipocyte 2014, 3(3):206-211.
27. Cawthorn W.P., Scheller E.L., Learman B.S., Parlee S.D., Simon B.R., Mori H., et al. Bone marrow adipose tissue is an endocrine organ that contributes to increased circulating adiponectin during caloric restriction. Cell Metabolism 2014, 20(2):368-375.
28. Scheller E.L., Doucette C.R., Learman B.S., Cawthorn W.P., Khandaker S., Schell B., et al. Region-specific variation in the properties of skeletal adipocytes reveals regulated and constitutive marrow adipose tissues. Nature Communication 2015, 6:7808.
29. Scheller E.L., Troiano N., Vanhoutan J.N., Bouxsein M.A., Fretz J.A., Xi Y., et al. Use of osmium tetroxide staining with microcomputerized tomography to visualize and quantify bone marrow adipose tissue in vivo. Methods in Enzymology 2014, 537:123-139.
30. Parlee S.D., Lentz S.I., Mori H., MacDougald O.A. Quantifying size and number of adipocytes in adipose tissue. Methods in Enzymology 2014, 537:93-122.
31. Parlee S.D., Simon B.R., Scheller E.L., Alejandro E.U., Learman B.S., Krishnan V., et al. Administration of saccharin to neonatal mice influences body composition of adult males and reduces body weight of females. Endocrinology 2014, 155(4):1313-1326.
32. Liew C.W., Bochenski J., Kawamori D., Hu J., Leech C.A., Wanic K., et al. The pseudokinase tribbles homolog 3 interacts with ATF4 to negatively regulate insulin exocytosis in human and mouse beta cells. Journal of Clinical Investigation 2010, 120(8):2876-2888.
33. Reue K., Peterfy M. Mouse models of lipodystrophy. Current Atherosclerosis Reports 2000, 2(5):390-396.
34. Savage D.B. Mouse models of inherited lipodystrophy. Disease Models & Mechanisms 2009, 2(11-12):554-562.
35. Reitman M.L., Arioglu E., Gavrilova O., Taylor S.I. Lipoatrophy revisited. Trends in Endocrinology & Metabolism 2000, 11(10):410-416.
36. Gesta S., Tseng Y.H., Kahn C.R. Developmental origin of fat: tracking obesity to its source. Cell 2007, 131(2):242-256.
37. Cristancho A.G., Lazar M.A. Forming functional fat: a growing understanding of adipocyte differentiation. Nature Reviews Molecular Cell Biology 2011, 12(11):722-734.
38. Lefterova M.I., Lazar M.A. New developments in adipogenesis. Trends in Endocrinology & Metabolism 2009, 20(3):107-114.
39. Garg A. Lipodystrophies. American Journal of Medicine 2000, 108(2):143-152.
40. Senior B. Lipodystrophic muscular hypertrophy. Archives of Disease in Childhood 1961, 36:426-431.
41. Liu X., Magee D., Wang C., McMurphy T., Slater A., During M., et al. Adipose tissue insulin receptor knockdown via a new primate-derived hybrid recombinant AAV serotype. Molecular Therapy, Methods & Clinical Development 2014, 1.
42. Gesta S., Bluher M., Yamamoto Y., Norris A.W., Berndt J., Kralisch S., et al. Evidence for a role of developmental genes in the origin of obesity and body fat distribution. Proceedings of the National Academy of Sciences United States of America 2006, 103(17):6676-6681.
43. Tchkonia T., Thomou T., Zhu Y., Karagiannides I., Pothoulakis C., Jensen M.D., et al. Mechanisms and metabolic implications of regional differences among fat depots. Cell Metabolism 2013, 17(5):644-656.
44. Hong K.Y., Bae H., Park I., Park D.Y., Kim K.H., Kubota Y., et al. Perilipin+ embryonic preadipocytes actively proliferate along growing vasculatures for adipose expansion. Development 2015, 142(15):2623-2632.
45. Trujillo M.E., Scherer P.E. Adipose tissue-derived factors: impact on health and disease. Endocrine Reviews 2006, 27(7):762-778.
46. Viengchareun S., Zennaro M.C., Pascual-Le Tallec L., Lombes M. Brown adipocytes are novel sites of expression and regulation of adiponectin and resistin. FEBS Letters 2002, 532(3):345-350.
47. Semple R.K., Halberg N.H., Burling K., Soos M.A., Schraw T., Luan J., et al. Paradoxical elevation of high-molecular weight adiponectin in acquired extreme insulin resistance due to insulin receptor antibodies. Diabetes 2007, 56(6):1712-1717.
48. Semple R.K., Soos M.A., Luan J., Mitchell C.S., Wilson J.C., Gurnell M., et al. Elevated plasma adiponectin in humans with genetically defective insulin receptors. Journal of Clinical Endocrinology and Metabolism 2006, 91(8):3219-3223.
49. Abel E.D., Peroni O., Kim J.K., Kim Y.B., Boss O., Hadro E., et al. Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature 2001, 409(6821):729-733.
50. Perry R.J., Zhang D., Zhang X.M., Boyer J.L., Shulman G.I. Controlled-release mitochondrial protonophore reverses diabetes and steatohepatitis in rats. Science 2015, 347(6227):1253-1256.
51. Lafontan M., Langin D. Lipolysis and lipid mobilization in human adipose tissue. Progress in Lipid Research 2009, 48(5):275-297.
52. Arner P., Langin D. Lipolysis in lipid turnover, cancer cachexia, and obesity-induced insulin resistance. Trends in Endocrinology & Metabolism 2014, 25(5):255-262.
53. Wilcox G. Insulin and insulin resistance. Clinical Biochemist Reviews 2005, 26(2):19-39.
54. Brown M.S., Goldstein J.L. Selective versus total insulin resistance: a pathogenic paradox. Cell Metabolism 2008, 7(2):95-96.
55. Fromme T., Klingenspor M. Uncoupling protein 1 expression and high-fat diets. American Journal of Physiology, Regulatory, Integrative and Comparative Physiology 2011, 300(1):R1-R8.
56. Cannon B., Nedergaard J. Brown adipose tissue: function and physiological significance. Physiological Reviews 2004, 84(1):277-359.
57. Mori M.A., Thomou T., Boucher J., Lee K.Y., Lallukka S., Kim J.K., et al. Altered miRNA processing disrupts brown/white adipocyte determination and associates with lipodystrophy. The Journal of Clinical Investigation 2014, 124(8):3339-3351.
58. Golozoubova V., Hohtola E., Matthias A., Jacobsson A., Cannon B., Nedergaard J. Only UCP1 can mediate adaptive nonshivering thermogenesis in the cold. FASEB Journal 2001, 15(11):2048-2050.
59. Brown M.S., Goldstein J.L. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 1997, 89(3):331-340.
60. Horton J.D., Goldstein J.L., Brown M.S. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. The Journal of Clinical Investigation 2002, 109(9):1125-1131.
61. Sugden M.C., Watts D.I., Marshall C.E., McCormack J.G. Brown-adipose-tissue lipogenesis in starvation: effects of insulin and (-) hydroxycitrate. Bioscience Reports 1982, 2(5):289-297.
62. Probst I., Unthan-Fechner K. Activation of glycolysis by insulin with a sequential increase of the 6-phosphofructo-2-kinase activity, fructose-2,6-bisphosphate level and pyruvate kinase activity in cultured rat hepatocytes. European Journal of Biochemistry 1985, 153(2):347-353.
63. Cooney G.J., Newsholme E.A. The maximum capacity of glycolysis in brown adipose tissue and its relationship to control of the blood glucose concentration. FEBS Letters 1982, 148(2):198-200.